|
|
|
Volumn 5, Issue 4 SUPPL. 2, 2007, Pages 63-65
|
|
Novel thrombopoietic agents: Preliminary activity, potential benefit
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AKR 501;
AMG 531;
ANTINEOPLASTIC AGENT;
COLONY STIMULATING FACTOR;
CORTICOSTEROID;
CYTOKINE;
ELTROMBOPAG;
ERYTHROPOIETIN;
HEMOSTATIC AGENT;
KERATINOCYTE GROWTH FACTOR;
NEW DRUG;
PLACEBO;
RECOMBINANT INTERLEUKIN 11;
RITUXIMAB;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
ANEMIA;
BLEEDING DISORDER;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOPENIA;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
HUMAN;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
MALIGNANT NEOPLASTIC DISEASE;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
MYELODYSPLASTIC SYNDROME;
NEUTROPENIA;
PATIENT CARE;
QUALITY OF LIFE;
SINGLE DRUG DOSE;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
ANTINEOPLASTIC AGENTS;
CARRIER PROTEINS;
COLONY-STIMULATING FACTORS;
HUMANS;
PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;
RECEPTORS, FC;
RECEPTORS, THROMBOPOIETIN;
THROMBOPOIESIS;
|
|
EID: 34250650894
PISSN: 15446794
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
